Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/360
Title: Ankilozlovchi spondiloartritda IL-17 ning kasallik kechishidagi axamiyati
Authors: Axmedov X.S., Raximov S.S.
Keywords: ankilozlovchi spondiloartrit. IL-17, AS- DAS, BASDAI, Shober sinamasi.
Issue Date: 2024
Citation: Toshkent
Series/Report no.: UO'K;616.711-002.72-007.274-085
Abstract: ankilozan spondilitda IL-17 zardobining kasallik faolligi parametrlari bilan bog’liqligini o’rgan- ish. Material va usullar: tadqiqotga ASAS 2023 mezon- lari asosida Toshkent tibbiyot akademiyasida ankilozan spondilit tashxisi qo‘yilgan o‘zbek millatiga mansub 40 nafar bemor ishtirok etdi. Bemorlarning o’rtacha yoshi 53,58±9,28 yosh, tana massasi indeksi 24,36±3,23 kg/m . Natijalar: CRO va IL-17 ning o’rtacha qiymatlari mos rav- ishda 0,3 (0,10-5,70) mg / dL va 9,30 (7,70-13,60) pg/dL edi. ASDAS-CRO tizimiga ko’ra, bemorlarda kasallik faolli- gi yuqori (62,5%), o’rtacha (35%) va faol emas (2,5%). IL- 17 darajalari AS bilan og’rigan bemorlarda kasallik faol- ligi bilan chambarchas bog’liq edi. Xulosa: spearmanning daraja testi IL-17 darajalari va ASDAS-CRO ballari o’rtasi- dagi munosabatni tahlil qilish uchun ishlatilishi mumkin.
URI: http://repo.tma.uz/xmlui/handle/1/360
ISSN: 2181-7812
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
Axmedov X.S., Raximov S.S..pdfAnkilozlovchi spondiloartritda IL-17 ning kasallik kechishidagi axamiyati750.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.